 CUPERTINO, Calif., Sept. 26, 2022 GLOBE NEWSWIRE -- Reviva Pharmaceuticals Holdings, Inc. NASDAQ: RVPH Reviva or the Company, a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system CNS, cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the Lytham Partners Fall 2022 Investor Conference being held September 2829, 2022 and invites investors to participate via virtual one-on-one meetings. Please see additional details below: 